IL1B and type 1 diabetes mellitus: For instance, in T1DM, IL-1β promoted C/EBP homologous protein (CHOP)-dependent cell death and cardiac dysfunction, which is attenuated by the administration of recombinant IL-1 receptor antagonist (Liu et al., 2015).